English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 18 April 2019, 20:00 HKT/SGT
Share:
    

Source: ReShape Lifesciences Inc.
ReShape Lifesciences Announces Distribution in Australia

SAN CLEMENTE, CA & MELBOURNE, AU, Apr 18, 2019 - (ACN Newswire) - ReShape Lifesciences™, a developer of minimally invasive medical devices to treat obesity and metabolic diseases, announces that as of April 1, 2019, the company was selling its LAP-BAND® product in the Australian market through a relationship with Satori Healthcare. Satori Healthcare is a medical device distributor focused on the Australian bariatric market.

The founder of Satori Healthcare has over 20 years of experience in the medical device industry, including 6 years of direct responsibility for LAP-BAND while it was owned by Allergan and Apollo Endosurgery respectively. Concurrent with this relationship, ReShape Lifesciences has fully taken over all distribution of the LAP-BAND product in Australia from Apollo Endosurgery, Inc. and will subsequently be recognizing revenue from sales of the product in Australia.

Over 120,000 LAP-BAND procedures have taken place in Australia since the product was launched in the country, making Australia one of the largest worldwide markets for LAP-BAND outside of the U.S. Australia was one of the early adopters of the LAP-BAND technology and has produced some of the strongest data and research on the product. According to the OECD 2017 Obesity Update, based on self-reported data, 27.9% of the Australian adult population are obese, the fifth highest obesity rate of any developed country.

About ReShape Lifesciences Inc

ReShape Lifesciences™ (OTCQB: RSLS) is a medical device company focused on technologies to treat obesity and metabolic diseases. The FDA-approved LAP-BAND® Adjustable Gastric Banding System is designed to provide minimally invasive long-term treatment of severe obesity and is an alternative to more invasive surgical stapling procedures such as gastric bypass or sleeve gastrectomy. The ReShape Vest™ System is an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach, emulating the gastric volume reduction effect of conventional weight-loss surgery. It is intended to enable rapid weight loss in obese and morbidly obese patients without permanently changing patient anatomy.

Investor Contact:
Scott Youngstrom
Chief Financial Officer
ReShape Lifesciences Inc.
+1-949-429-6680 x106
[email protected]

SOURCE: ReShape Lifesciences Inc.

Topic: Press release summary
Sectors: BioTech, HealthCare
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2019 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Yangon International Airport welcomes IndiGo's inaugural flight from Kolkata  
Sept 20, 2019 20:00 HKT/SGT
HKTDC extends partnership with Veronafiere to 2021  
Sept 20, 2019 18:00 HKT/SGT
Eisai and Meiji Announce Parkinson's Disease Treatment Equfina Tablets (Safinamide Mesilate) Approved In Japan  
Sept 20, 2019 15:13 HKT/SGT
MHIENG Completes Large-Scale Polyethylene Production Train for ExxonMobil in Beaumont, Texas  
Sept 20, 2019 15:05 HKT/SGT
Toyota to Hold 30th Toyota Automobile Museum Classic Car Festival in Japan  
Sept 20, 2019 15:02 HKT/SGT
Cumulative Global Sales of the Toyota Land Cruiser Series Surpass 10 Million Units  
Sept 20, 2019 14:55 HKT/SGT
The Honda Prize 2019 Awarded to Dr. Geoffrey Hinton, Professor Emeritus, the University of Toronto and Chief Scientific Adviser, Vector Institute  
Sept 20, 2019 14:48 HKT/SGT
Fujitsu and PeptiDream Leverage Quantum-Inspired Tech in Joint Research to Accelerate Drug Discovery  
Sept 20, 2019 11:03 HKT/SGT
Hitachi: Chaskey Message Authentication Technology Developed for IoT Systems Supporting Key Infrastructure Adopted by ISO/IEC for Lightweight Cryptography  
Sept 20, 2019 10:05 HKT/SGT
Eisai's Promotion and Distribution Agreement with Mylan India for Eribulin Second Brand in India  
Sept 20, 2019 08:40 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2019 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6653 1210 | Tokyo: +81 3 6859 8575